🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: VKAs

Found 17 matching trials

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

PHASE3

This program is a comprehensive evaluation of rheumatic valvular heart dise...

Status

Completed

Location

Princess Marina Hospital

Start Date

2016-08-22

Trial ID

NCT02832544

Treatments Being Tested

Rivaroxaban (20 mg)Vitamin K antagonists (VKA)

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

N/A

Background: Elastin is a unique protein providing elasticity, resilience an...

Status

Unknown

Location

Canisius Wilhelmina Hospital

Start Date

2017-10-31

Trial ID

NCT03285100

Treatments Being Tested

Venipuncture

Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine

N/A

Despite the rise in prescriptions for direct oral anticoagulants,Vitamin K ...

Status

Completed

Location

Uhmontpellier

Start Date

2017-07-01

Trial ID

NCT03914053

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

N/A

The multicenter registry will collect clinical data from 1600 patients with...

Status

Completed

Location

Krankenhaus St. Josef Braunau

Start Date

2016-04

Trial ID

NCT02663076

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

N/A

The main objective of this project is to evaluate savings in direct costs a...

Status

Completed

Location

Multiple Locations

Start Date

2015-06-01

Trial ID

NCT03462446

Treatments Being Tested

Rivaroxaban (Xarelto, BAY59-7939)Vitamin K antagonists (VKAs)

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

N/A

By evaluating routine clinical practice data from the UK primary care datab...

Status

Completed

Location

Many locations

Start Date

2020-05-01

Trial ID

NCT04297072

Treatments Being Tested

Rivaroxaban (Xarelto, BAY-597939)VKAs

Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

The purpose of this pilot study is to collect data on pregnancies with mech...

Status

Recruiting

Location

Mount Sinai Hospital

Start Date

2026-05-26

Trial ID

NCT07658989

Treatments Being Tested

LMWH and LDA Vitamin K antagonists (e.g warfarin)+/- LDA Sequential therapy +/- LDA

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

N/A

According to recent guidelines, long-term anticoagulation is recommended fo...

Status

Completed

Location

Multiple Locations

Start Date

2014-01

Trial ID

NCT02090543

Treatments Being Tested

Phenprocoumon (Marcumar)Rivaroxaban (Xarelto, BAY-59 7939)

Evaluating of CREATIF an Anti-coagulation Clinic

Main objective: To evaluate the impact of CREATIF (an anticoagulation clini...

Status

Completed

Location

Service d'hématologie - Hôpital Lariboisière

Start Date

2011-05

Trial ID

NCT01349530

Treatments Being Tested

Evaluating of usual care Evaluation of CREATIF

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

N/A

Antiphospholipid syndrome (APS) is a thrombotic disease requiring prolonged...

Status

Not Yet Recruiting

Location

Central Hospital, Nancy, France

Start Date

2025-09-15

Trial ID

NCT06884384

Treatments Being Tested

Additional blood collection during routine blood sampling at the inclusion (33.9 ml) and at the thrombotic recurrence (between 3.5 and 5 ml)Completion of a questionnaire on compliance with anticoagulant treatment Completion of a questionnaire on satisfaction with treatment anticoagulant

Previous Next